In 4 posters presented at the Hematology/Oncology Pharmacy Association Annual Conference 2024, researchers addressed pharmacists’ role in managing patients’ anticancer medications.
Researchers highlighted the increasing scope of pharmacists’ ability to improve anticancer medication adherence and minimize adverse effects in multiple types of clinical settings. They also offered suggestions to implement specific pharmacist functions and ensure further mitigation of treatment disruptions.
The researchers addressed interventions from a health-system specialty pharmacy (HSSP), a pharmacist-led telehealth toxicity monitoring initiative, the monitoring of patients initiating poly ADP-ribose polymerase inhibitor (PARPi) therapy, and posttransplant vaccination compliance.
Read more of our coverage from the HOPA Annual Conference 2024.
Continuous Glucose Monitoring Could Improve Outcomes in Pediatric Patients With Leukemia/Lymphoma
July 2nd 2024A pilot study presented at the American Diabetes Association 84th Scientific Sessions showed that CGM technology could produce reliable results without complications in children with leukemia/lymphoma at risk for hyperglycemia.